Olympus 2002 Annual Report Download - page 15

Download and view the complete annual report

Please find page 15 of the 2002 Olympus annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 50

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50

13
hospitals and laboratories to high volume commercial labora-
tories. Same reagents and consumables, consistent user inter-
face and accurate test results assure greater productivity and
cost savings. Sales showed significant growth primarily due to
the successful development of Olympus System Business
Program in Europe that offers a full product package of
analyzer instruments, reagents, consumable supplies and
services, receiving payment revenue according to the number
of test procedures performed.
Biological Microscopes
Sales of biological microscopes increased 20.5% to
¥32,225 million (US$258 million). Olympus is on the
leading edge of optical technology in biological micro-
scopes, and boasts a 30% share of the world market. During
fiscal 2002, sales increased, mainly in the international mar-
ket, due partly to positive trend in the research and educa-
tional market in Europe.
respiratory and urinology
systems as well, and these
require surgical endoscopes
and operating equipment
with which to treat
malignancies. More
widespread use of these
products is expected along with the demand for an improved
quality of life for patients. Ultrasonic endoscopes, further-
more, by showing images not just of the external structure but
also the interior of the affected area, have produced a dramat-
ic increase in the accuracy of cancer diagnosis.
Clinical Analyzers
Sales of chemistry-immuno analyzers and reagents
increased 23.6% to ¥30,382 million (US$243 million).
From 400 to 6,600 tests per hour, Olympus offers the
broadest standardized line of chemistry-immuno analyzers
and reagents for serum and urine testing, meeting the high
productivity demands of customers from small to mid-size
cal
Biological microscopes,
IX81 (left) and IX71
Clinical analyzer,
the AU5400 series